| Symbol |
Company |
Application # |
Date |
Title |
| ENZ | Enzo Biochem | 20120115169 | 20120510 | Hydroxycholesterol immunoassay |
| ENZ | Enzo Biochem | 20120071399 | 20120322 | Sulfation of wnt pathway proteins |
| ENZ | Enzo Biochem | 20120064577 | 20120315 | Mutant t7 polymerases |
| ENZ | Enzo Biochem | 20120052481 | 20120301 | Assays for detecting modified compounds |
| ENZ | Enzo Biochem | 20120040430 | 20120216 | Compositions useful for detection or quantification of desirable target molecules, novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes |
| ENZ | Enzo Biochem | 20110318788 | 20111229 | Multisignal labeling reagents and processes and uses therefor |
| ENZ | Enzo Biochem | 20110098441 | 20110428 | Label target and labeling reagents comprising backbones with at least two consecutive peptide bonds |
| ENZ | Enzo Biochem | 20110086021 | 20110414 | Sclerostin and the inhibition of wnt signaling and bone formation |
| ENZ | Enzo Biochem | 20110028692 | 20110203 | Multisignaling oligomeric or polymeric compositions comprising labeled moieties and binding partners |
| ENZ | Enzo Biochem | 20100324268 | 20101223 | Multi-oligomeric or multi--polymeric compositions comprising labeled moieties and binding partners |
| ENZ | Enzo Biochem | 20100298308 | 20101125 | Compositions and methods for bone formation and remodeling |
| ENZ | Enzo Biochem | 20100298200 | 20101125 | Compounds and assays for controlling wnt activity |
| ENZ | Enzo Biochem | 20100278741 | 20101104 | Novel compositions including sphingosine kinase type 1 inhibitors, and processes for using same |
| ENZ | Enzo Biochem | 20100273145 | 20101028 | Assay method utilizing polynucleotide sequences |
| ENZ | Enzo Biochem | 20100228008 | 20100909 | Dyes linked to target molecules, oligonucleotides or polynucleotides comprising dye molecules, composite dyes and other compositions useful for detecting or quantifying desirable target molecules |
| ENZ | Enzo Biochem | 20100221358 | 20100902 | Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic disorders |
| ENZ | Enzo Biochem | 20100093004 | 20100415 | Autophagy and phospholipidosis pathway assays |
| ENZ | Enzo Biochem | 20100093649 | 20100415 | Synthetic glycolipid analogues and derivatives for the treatment of pathologic disorders |
| ENZ | Enzo Biochem | 20100081159 | 20100401 | Profiling reactive oxygen, nitrogen and halogen species |
| ENZ | Enzo Biochem | 20100074891 | 20100325 | Sclerostin and the inhibition of wnt signaling and bone formation |
| ENZ | Enzo Biochem | 20100068752 | 20100318 | Novel fluorescent dyes and compounds, methods and kits useful for identifying specific organelles and regions in cells of interest |
| ENZ | Enzo Biochem | 20100062460 | 20100311 | Novel fluorochromes for organelle tracing and multi-color imaging |
| ENZ | Enzo Biochem | 20100062429 | 20100311 | Fluorochromes for organelle tracing and multi-color imaging |
| ENZ | Enzo Biochem | 20100041599 | 20100218 | Compositions and methods for bone formation, bone remodeling and toxin protection |
| ENZ | Enzo Biochem | 20100041020 | 20100218 | Methods for detecting the presence, location or quantity of targets using novel dyes |
| ENZ | Enzo Biochem | 20100035959 | 20100211 | Novel sphingosine kinase type 1 inhibitors, compositions and processes for using same |
| ENZ | Enzo Biochem | 20100021500 | 20100128 | Processes for treating subjects carrying viral infectious agent |
